Graft Polymer (UK) PLC (GB:GPL) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Graft Polymer (UK) PLC, a biotechnology firm, has partnered with Awakn Life Sciences Corp. to conduct groundbreaking research at the University of Nottingham, aimed at developing new mental health therapeutics for conditions like PTSD. The research focuses on evaluating aminoindane compounds for their ability to enhance social cognition and pro-social behaviors in rodent models. Results from the two-month study are anticipated by the end of 2024, marking a critical step in addressing trauma-related mental health disorders.
For further insights into GB:GPL stock, check out TipRanks’ Stock Analysis page.
